14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival

Purpose: Androgen receptor is an essential transcriptional factor that contributes to the development and progression of prostate cancer. In this study, we investigated the androgen regulation and functional analysis of 14-3-3ζ in prostate cancer. Experimental Design: Using chromatin immunoprecipitation (ChIP) combined with DNA microarray (ChIP-chip) analysis in LNCaP cells, we identified a functional androgen receptor–binding site in the downstream region of the 14-3-3ζ gene. Androgen regulation was examined by quantitative reverse transcription PCR and Western blot analysis. Prostate cancer cells stably expressing 14-3-3ζ and siRNA knockdown were used for functional analyses. We further examined 14-3-3ζ expression in clinical samples of prostate cancer by immunohistochemistry and quantitative reverse transcription PCR. Results: Androgen-dependent upregulation of 14-3-3ζ was validated at the mRNA and protein levels. The 14-3-3ζ gene is favorable for cancer-cell survival, as its ectopic expression in LNCaP cells contributes to cell proliferation and the acquired resistance to etoposide-induced apoptosis. 14-3-3ζ expression was associated with androgen receptor transcriptional activity and prostate-specific antigen (PSA) mRNA expression. Immunoprecipitation indicated that 14-3-3ζ was associated with androgen receptor in the nucleus. Clinicopathologic studies further support the relevance of 14-3-3ζ in prostate cancers, as its higher expression is associated with malignancy and lymph node metastasis. Conclusions: 14-3-3ζ is a novel androgen-responsive gene that activates proliferation, cell survival, and androgen receptor transcriptional activity. 14-3-3ζ may facilitate the progression of prostate cancer. Clin Cancer Res; 18(20); 5617–27. ©2012 AACR.

[1]  T. Pawson,et al.  Proteomic, Functional, and Domain-Based Analysis of In Vivo 14-3-3 Binding Proteins Involved in Cytoskeletal Regulation and Cellular Organization , 2004, Current Biology.

[2]  Mong-Hong Lee,et al.  14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth , 2003, Molecular and Cellular Biology.

[3]  J. Reichardt,et al.  Hormones and prostate cancer: Current perspectives and future directions , 2002, The Prostate.

[4]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Oka,et al.  Gains of 8q23‐qter and 20q and loss of 11q22‐qter in esophageal squamous cell carcinoma associated with lymph node metastasis , 2000, Cancer.

[6]  G. Tzivion,et al.  14-3-3 proteins as potential oncogenes. , 2006, Seminars in cancer biology.

[7]  K. Horie-Inoue,et al.  14-3-3σ is down-regulated in human prostate cancer , 2004 .

[8]  Dihua Yu,et al.  14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling. , 2008, Cancer research.

[9]  Tohru Natsume,et al.  JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage , 2005, Nature Cell Biology.

[10]  Robyn L Prueitt,et al.  Tumor immunobiological differences in prostate cancer between African-American and European-American men. , 2008, Cancer research.

[11]  J. Isaacs,et al.  The Prostate 69 : 1724 ^ 1729 ( 2009 ) TissueCultureMedia SupplementedWith 10 % Fetal Calf SerumContains aCastrate Levelof Testosterone , 2009 .

[12]  T. Visakorpi,et al.  Alterations of androgen receptor in prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  Eric S. Lander,et al.  Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse , 2005, Cell.

[14]  A. Aitken,et al.  14-3-3 proteins on the MAP. , 1995, Trends in biochemical sciences.

[15]  A. Levine,et al.  Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. , 2010, Cancer research.

[16]  B. Verdoodt,et al.  Characterization of 14-3-3sigma Dimerization Determinants: Requirement of Homodimerization for Inhibition of Cell Proliferation , 2006, Cell cycle.

[17]  Fuminori Tsuruta,et al.  JNK promotes Bax translocation to mitochondria through phosphorylation of 14‐3‐3 proteins , 2004, The EMBO journal.

[18]  Haian Fu,et al.  Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. , 2006, Seminars in cancer biology.

[19]  E. Valverius,et al.  Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  P. Kantoff,et al.  The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Fuminori Tsuruta,et al.  JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3 , 2005, The Journal of cell biology.

[22]  D. Campbell,et al.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. , 2004, The Biochemical journal.

[23]  F. Khuri,et al.  Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation , 2008, Proceedings of the National Academy of Sciences.

[24]  Esther B. E. Becker,et al.  JNK Phosphorylation and Activation of BAD Couples the Stress-activated Signaling Pathway to the Cell Death Machinery* , 2002, The Journal of Biological Chemistry.

[25]  Jorge L Yao,et al.  Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. , 2007, Molecular endocrinology.

[26]  H. Aburatani,et al.  Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. , 2009, Cancer research.

[27]  M. Sadar,et al.  14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens. , 2007, Cancer letters.

[28]  H. Aburatani,et al.  Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells , 2011, Oncogene.

[29]  Esther B. E. Becker,et al.  Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons , 2008, Science.

[30]  Mong-Hong Lee,et al.  14-3-3 sigma positively regulates p53 and suppresses tumor growth. , 2003, Molecular and cellular biology.

[31]  H. Hermeking.  The 14-3-3 cancer connection , 2003, Nature Reviews Cancer.

[32]  Heinz Becker,et al.  Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  John T. Wei,et al.  Integrative molecular concept modeling of prostate cancer progression , 2007, Nature Genetics.

[34]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[35]  H. Fujita,et al.  The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor , 2004, Cancer Research.

[36]  D. Morrison,et al.  The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. , 2009, Trends in cell biology.

[37]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[38]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[39]  W. Ha,et al.  The differential proteome profile of stomach cancer: identification of the biomarker candidates. , 2004, Oncology research.

[40]  D. Schadendorf,et al.  Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two‐dimensional electrophoresis , 2000, Electrophoresis.

[41]  S. Cawley,et al.  Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.

[42]  K. Tomer,et al.  Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer , 2005, Clinical Cancer Research.

[43]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[44]  B. Haendler,et al.  Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3η , 2001, Molecular and Cellular Endocrinology.

[45]  A. Aitken.  14-3-3 proteins: a historic overview. , 2006, Seminars in cancer biology.

[46]  Seong-Jin Kim,et al.  14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1 , 2010, Molecules and cells.

[47]  Dihua Yu,et al.  14-3-3ζ as a prognostic marker and therapeutic target for cancer , 2010, Expert opinion on therapeutic targets.

[48]  F. S. French,et al.  14-3-3η Amplifies Androgen Receptor Actions in Prostate Cancer , 2009, Clinical Cancer Research.

[49]  K. Horie-Inoue,et al.  14-3-3sigma is down-regulated in human prostate cancer. , 2004, Biochemical and biophysical research communications.

[50]  M. Niemantsverdriet,et al.  Cellular functions of 14-3-3ζ in apoptosis and cell adhesion emphasize its oncogenic character , 2007, Oncogene.

[51]  H. Aburatani,et al.  Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis , 2007, Oncogene.

[52]  Shilpi Arora,et al.  Identification of differentially expressed genes in oral squamous cell carcinoma , 2005, Molecular carcinogenesis.

[53]  D. Tindall,et al.  The role of androgens and the androgen receptor in prostate cancer. , 2002, Cancer letters.

[54]  M. V. van Hemert,et al.  14‐3‐3 proteins: key regulators of cell division, signalling and apoptosis , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[55]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[56]  J. Cheville,et al.  Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. , 2003, Cancer research.

[57]  C. Walker,et al.  14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). , 2002, Cancer research.

[58]  Satoshi Inoue,et al.  Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. , 2002, Nature.

[59]  F. Révillion,et al.  Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells , 2001 .